Atul Pande Insider Profile

4 Followers
Atul Pande, Director at Sio Gene Therapies, holds 114.41K shares in Immunovant (Ticker: IMVT), holds 0.00 shares in Karuna Therapeutics (Ticker: KRTX), holds 33.37K shares in Sio Gene Therapies (Ticker: SIOX).
tipranks
Atul Pande

Atul Pande
Sio Gene Therapies (SIOX)
Director

Ranked #6,621 out of 99,218 Corporate Insiders

Profitable Transactions

33%
2 out of 6 Profitable Transactions

Average Return

+47.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
A breakdown of Atul Pande's holdings

Insider Roles

Immunovant
(IMVT)
Director
Roles that Atul Pande holds in companies

Most Profitable Insider Trade

Stock:
Immunovant
(IMVT)
Rating:Informative Buy
Date:Oct 04, 2022 - Oct 04, 2023
Return:+316.20%
The most profitable trade made by Atul Pande

Atul Pande's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SIOX
Sio Gene Therapies
Nov 25, 2020
Informative Buy
23.30K
$15.95K
KRTX
Karuna Therapeutics
Mar 18, 2024
Uninformative Sell
326.70K
$0.00
Immunovant
Apr 04, 2024
Director
Uninformative Buy
$3.47M
List of latest transactions for each holding click on a transaction to see Atul Pande's performance on stock

Atul Pande insider profile FAQ

What is the percentage of profitable transactions made by Atul Pande?
The percentage of profitable transactions made by Atul Pande is 33%.
    What is the average return per transaction made by Atul Pande?
    The average return per transaction made by Atul Pande is 47.80%.
      What stocks does Atul Pande hold?
      Atul Pande holds: SIOX, KRTX, IMVT stocks.
        What was Atul Pande’s latest transaction?
        Atul Pande latest transaction was an Uninformative Buy of ―.
          What was Atul Pande's most profitable transaction?
          Atul Pande’s most profitable transaction was an Informative Buy of IMVT stock on October 4, 2022. The return on the trade was 316.20%.
            What is Atul Pande's role in Sio Gene Therapies?
            Atul Pande's role in Sio Gene Therapies is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.